GlassScriptPhysician profile
Isaac W Cline
NPI 1245592823
$5,788.12
in general payments reported to CMS, 2019-2025
23 companies · $1,050 in 2025
The $1,050 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $601 · 2020: $475 · 2021: $1,147 · 2022: $978 · 2023: $651 · 2024: $886 · 2025: $1,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,565 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,565.09 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,066.03 | 2019-2025 | Rinvoq, Mavyret, Skyrizi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $922.77 | 2019-2025 | Xifaxan, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $883.51 | 2019-2025 | Entyvio, Eohilia |
| Celgene Corporation | $388.29 | 2021-2024 | Zeposia |
| Pfizer INC. | $357.50 | 2019-2025 | |
| Janssen Biotech, INC. | $206.88 | 2019-2022 | |
| Gilead Sciences, INC. | $197.59 | 2020-2024 | |
| Ardelyx, INC. | $148.37 | 2023-2025 | Ibsrela |
| Braintree Laboratories, INC. | $96.79 | 2019-2023 | Suflave |
| Aimmune Therapeutics, INC. | $69.36 | 2025 | Zenpep |
| Redhill Biopharma INC. | $69.06 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $63.43 | 2022-2023 | Dupixent |
| Lilly USA, LLC | $60.70 | 2025 | Omvoh |
| Intercept Pharmaceuticals, INC. | $45.14 | 2020-2022 | |
| Novo Nordisk INC | $44.90 | 2025 | Wegovy |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $38.14 | 2025 | Voquezna |
| Ferring Pharmaceuticals INC. | $31.24 | 2019-2023 | Rebyota |
| Medtronic, INC. | $20.05 | 2025 | Pillcam |
| Nestle Healthcare Nutrition INC. | $19.81 | 2023 | |
| Echosens North America, INC. | $15.83 | 2024 | Fibroscan |
| Amgen INC. | $15.61 | 2022 | |
| Boston Scientific Corporation | $15.56 | 2022 | |
| Ironwood Pharmaceuticals, INC | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isaac Cline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.